FDA/stakeholder collaboration
This article was originally published in The Tan Sheet
Executive Summary
Public meetings scheduled in California (March 23) and North Carolina (April 12) to consider ways in which FDA can better leverage its resources and expertise by working with outside organizations. Proposed collaborative initiatives include patient/consumer education on the safe use of products and Internet drug marketing inspections. The Consumer Healthcare Products Association is a collaborative partner in the Product Quality Research Institute, an ongoing initiative aimed at fostering scientific research to support regulatory policy
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning